Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma

Objectives To evaluate the expression of brain‐derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB), and two downstream targets of this pathway, Akt and ribosomal protein S6 (RPS6), in normal oral mucosa (NOM), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC) and c...

Full description

Saved in:
Bibliographic Details
Published inOral diseases Vol. 25; no. 8; pp. 1925 - 1936
Main Authors Moraes, Juliana Kern de, Wagner, Vivian Petersen, Fonseca, Felipe Paiva, Amaral‐Silva, Gleyson Kleber do, de Farias, Caroline Brunetto, Pilar, Emily Ferreira Salles, Gregianin, Lauro, Roesler, Rafael, Vargas, Pablo Agustin, Martins, Manoela Domingues
Format Journal Article
LanguageEnglish
Published Denmark Wiley Subscription Services, Inc 01.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives To evaluate the expression of brain‐derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB), and two downstream targets of this pathway, Akt and ribosomal protein S6 (RPS6), in normal oral mucosa (NOM), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC) and correlate this expression with OSCC patients’ outcomes, cell senescence, and “stemness” profile. Materials and Methods Ten cases of NOM, 32 OL, and 72 primary OSCC were included. Immunohistochemical analysis for BDNF, TrkB, p‐TrkB, p‐Akt, and p‐RPS6 was performed. Cell senescence and stemness profile of OSCC were evaluated through p16 and BMI‐1 immunohistochemical expression, respectively. The slides were scanned into high‐resolution images and quantified through digital analysis. Results Oral squamous cell carcinoma presented increased expression of BDNF/TrkB/Akt pathway compared to NOM and OL. OSCC diagnosed in advanced clinical stages presented an upregulation of BDNF and p‐TrkB. BDNF and p‐Akt were identified as predictors of poor disease‐specific survival. The increase in stemness profile was correlated with a decrease in p‐TrkB and p‐Akt expression. Conclusions BDNF/TrkB/Akt pathway is significantly increased in malignant cells from OSCC. Moreover, BDNF and Akt represent biomarkers capable to predict a poor prognosis of OSCC patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1354-523X
1601-0825
DOI:10.1111/odi.13190